These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25888634)

  • 1. RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation.
    Schmidt SV; Seibert S; Walch-Rückheim B; Vicinus B; Kamionka EM; Pahne-Zeppenfeld J; Solomayer EF; Kim YJ; Bohle RM; Smola S
    Oncotarget; 2015 Apr; 6(11):8635-47. PubMed ID: 25888634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis.
    Kearney CJ; Cullen SP; Clancy D; Martin SJ
    FEBS J; 2014 Nov; 281(21):4921-34. PubMed ID: 25195660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High mobility group box 1 enables bacterial lipids to trigger receptor-interacting protein kinase 3 (RIPK3)-mediated necroptosis and apoptosis in mice.
    Meng R; Gu L; Lu Y; Zhao K; Wu J; Wang H; Han J; Tang Y; Lu B
    J Biol Chem; 2019 May; 294(22):8872-8884. PubMed ID: 31000631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair.
    Moriwaki K; Balaji S; McQuade T; Malhotra N; Kang J; Chan FK
    Immunity; 2014 Oct; 41(4):567-78. PubMed ID: 25367573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor.
    Cocco E; Varughese J; Buza N; Bellone S; Glasgow M; Bellone M; Todeschini P; Carrara L; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Lockwood CJ; Santin AD
    BMC Cancer; 2011 Jun; 11():263. PubMed ID: 21693061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.
    Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Otuski Y; Kobayashi H; Nakayama S; Miyazaki K
    Hum Pathol; 2012 Apr; 43(4):506-19. PubMed ID: 21889186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation.
    Schmidt SV; Seibert S; Walch-Rückheim B; Vicinus B; Kamionka EM; Pahne-Zeppenfeld J; Solomayer EF; Kim YJ; Bohle RM; Smola S
    Oncotarget; 2019 Jul; 10(43):4503-4504. PubMed ID: 31327986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha, and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma.
    Zijlmans HJ; Fleuren GJ; Baelde HJ; Eilers PH; Kenter GG; Gorter A
    Cancer; 2007 Feb; 109(3):556-65. PubMed ID: 17177206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
    Hannes S; Abhari BA; Fulda S
    Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.
    Berti FCB; Pereira APL; Cebinelli GCM; Trugilo KP; Brajão de Oliveira K
    Cytokine Growth Factor Rev; 2017 Apr; 34():1-13. PubMed ID: 28365229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
    Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
    Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment.
    Park HH; Kim HR; Park SY; Hwang SM; Hong SM; Park S; Kang HC; Morgan MJ; Cha JH; Lee D; Roe JS; Kim YS
    Mol Cancer; 2021 Aug; 20(1):107. PubMed ID: 34419074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of RIPK3 predicts necroptosis resistance in malignant melanoma.
    Geserick P; Wang J; Schilling R; Horn S; Harris PA; Bertin J; Gough PJ; Feoktistova M; Leverkus M
    Cell Death Dis; 2015 Sep; 6(9):e1884. PubMed ID: 26355347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
    Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
    Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A RIPK3-caspase 8 complex mediates atypical pro-IL-1β processing.
    Moriwaki K; Bertin J; Gough PJ; Chan FK
    J Immunol; 2015 Feb; 194(4):1938-44. PubMed ID: 25567679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix.
    Salarzaei M; van de Laar RLO; Ewing-Graham PC; Najjary S; van Esch E; van Beekhuizen HJ; Mustafa DAM
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells.
    Alcocer-González JM; Berumen J; Taméz-Guerra R; Bermúdez-Morales V; Peralta-Zaragoza O; Hernández-Pando R; Moreno J; Gariglio P; Madrid-Marina V
    Viral Immunol; 2006; 19(3):481-91. PubMed ID: 16987066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity.
    Snyder AG; Hubbard NW; Messmer MN; Kofman SB; Hagan CE; Orozco SL; Chiang K; Daniels BP; Baker D; Oberst A
    Sci Immunol; 2019 Jun; 4(36):. PubMed ID: 31227597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells.
    Heusinkveld M; de Vos van Steenwijk PJ; Goedemans R; Ramwadhdoebe TH; Gorter A; Welters MJ; van Hall T; van der Burg SH
    J Immunol; 2011 Aug; 187(3):1157-65. PubMed ID: 21709158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer.
    Wang HL; Xu H; Lu WH; Zhu L; Yu YH; Hong FZ
    Arch Gynecol Obstet; 2014 Jan; 289(1):155-62. PubMed ID: 23912529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.